Transcranial Magnetic Stimulation is Approved. Now What?

One year ago we reviewed the status of transcranial magnetic stimulation
for depression, and concluded with the following TCPR Verdict: “TMS for
depression: Approval is highly unlikely.” We were wrong. The FDA approved the Neuronetics Neurostar TMS machine for the treatment of patients with major depression who have failed one prior antidepressant trial. Did they make the right decision?

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.